Related Experiment Video
Updated: Sep 28, 2025

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Genetic background of mitral valve prolapse
Nicolò Azzola Guicciardi1,2, Michele De Bonis1,2, Chiara Di Resta2,3
1Cardiac Surgery, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy.
Abstract:
Mitral valve prolapse (MVP) has a prevalence of 2-3% among the population. It involves a heterogeneous group of patients with different expressions and according to the phenotype can be further divided into fibroelastic deficiency, which is mainly considered as a degeneration due to aging, and myxomatous disease, frequently associated with familiar clusters. Thus, MVP can be present in syndromic, when part of a well-defined syndrome, and non-syndromic forms. The latter occurs more often. To the second belong both familiar and isolated or sporadic forms. On one hand, among familial forms, although X-linked transmission related to FLNA gene was initially identified, further studies reported also autosomal dominant mode involving MVPP genes, including DCHS1. On the other hand, genome-wide association studies (GWAS), among unrelated patients, allowed the identification of new MVP-associated genes, such as LMCD1, GLIS, and TNS1. Moreover, single nucleotide polymorphisms (SNPs) on metalloproteinase genes have been related to MVP. Interestingly some genes such as DCHS1 and DZIP1 have been reported to be involved in both familiar and isolated forms. The present review aims to illustrate the updated genetic background of MVP.
Insights
Mitral valve prolapse (MVP) is a common condition with diverse genetic causes. This review details the updated genetic landscape of MVP, including familial and sporadic forms.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Mitral valve prolapse (MVP) affects 2-3% of the population and presents with heterogeneous phenotypes.
- MVP can be classified as fibroelastic deficiency (aging-related) or myxomatous disease (often familial).
- MVP exists in syndromic and non-syndromic forms, with non-syndromic being more prevalent.
Purpose of the Study:
- To provide an updated overview of the genetic factors contributing to mitral valve prolapse.
- To consolidate current knowledge on genes implicated in both familial and sporadic MVP.
- To highlight recent discoveries from genetic association studies.
Main Methods:
- Review of existing literature on MVP genetics.
- Analysis of findings from genome-wide association studies (GWAS).
- Examination of genetic transmission patterns (X-linked, autosomal dominant).
Main Results:
- Familial MVP is linked to genes like FLNA (X-linked) and MVPP genes (e.g., DCHS1, autosomal dominant).
- GWAS identified novel MVP-associated genes in unrelated patients, including LMCD1, GLIS, and TNS1.
- Single nucleotide polymorphisms in metalloproteinase genes and genes like DCHS1 and DZIP1 are associated with MVP in various forms.
Conclusions:
- The genetic architecture of MVP is complex, involving multiple genes and inheritance patterns.
- Understanding the genetic basis of MVP is crucial for diagnosis and potential therapeutic strategies.
- Continued genetic research is essential to fully elucidate MVP etiology.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

